Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients

ZG Dessie, T Zewotir - BMC infectious diseases, 2021 - Springer
Background Mortality rates of coronavirus disease-2019 (COVID-19) continue to rise across
the world. The impact of several risk factors on coronavirus mortality has been previously …

COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection

S Beyerstedt, EB Casaro, ÉB Rangel - European journal of clinical …, 2021 - Springer
COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2. Angiotensin-
converting enzyme 2 (ACE2) is not only an enzyme but also a functional receptor on cell …

COVID-19 in people with diabetes: understanding the reasons for worse outcomes

M Apicella, MC Campopiano, M Mantuano… - The lancet Diabetes & …, 2020 - thelancet.com
Since the initial COVID-19 outbreak in China, much attention has focused on people with
diabetes because of poor prognosis in those with the infection. Initial reports were mainly on …

Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract

T Flerlage, DF Boyd, V Meliopoulos… - Nature Reviews …, 2021 - nature.com
Influenza viruses cause annual epidemics and occasional pandemics of respiratory tract
infections that produce a wide spectrum of clinical disease severity in humans. The novel …

Predictors of mortality in hospitalized COVID‐19 patients: a systematic review and meta‐analysis

W Tian, W Jiang, J Yao, CJ Nicholson… - Journal of medical …, 2020 - Wiley Online Library
Mortality rates of coronavirus disease‐2019 (COVID‐19) continue to rise across the world.
Information regarding the predictors of mortality in patients with COVID‐19 remains scarce …

COVID-19: the inflammation link and the role of nutrition in potential mitigation

I Zabetakis, R Lordan, C Norton, A Tsoupras - Nutrients, 2020 - mdpi.com
The novel coronavirus disease (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has engulfed the world, affecting more than 180 …

Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis

B de Almeida-Pititto, PM Dualib, L Zajdenverg… - Diabetology & metabolic …, 2020 - Springer
Background The aim of this study is to evaluate the impact of diabetes, hypertension,
cardiovascular disease and the use of angiotensin converting enzyme inhibitors/angiotensin …

Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis

T Zhang, Q Mei, Z Zhang, JH Walline, Y Liu, H Zhu… - BMC medicine, 2022 - Springer
Background There is growing evidence that patients recovering after a severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may have a variety of acute …

Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss

R Kirwan, D McCullough, T Butler, F Perez de Heredia… - GeroScience, 2020 - Springer
The COVID-19 pandemic is an extraordinary global emergency that has led to the
implementation of unprecedented measures in order to stem the spread of the infection …

COVID-19 and diabetes: understanding the interrelationship and risks for a severe course

CP Landstra, EJP de Koning - Frontiers in endocrinology, 2021 - frontiersin.org
The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional.
On the one hand, diabetes mellitus is considered one of the most important risk factors for a …